Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Thematica Report: An investor's guide to market opportunities in 2023

An investor’s guide to market opportunities in 2023. Click here to access the report . Now that 2023 is in full swing, the start of a new year is an exciting time for investors — in the fast-moving world of investments, looking to the future is some...
Jocelyn Aspa | January 16, 2023 |

Clinical research and tools to address mental health

Our next company is Numinus Wellness Inc. (TSX:NUMI) . Numinus is using the power of psychedelic medicine to make great strides in addressing serious mental health issues. It recently announced its fiscal year 2024 results, which showed strong growth in its busines...
Ryan Dhillon | December 14, 2023 |

Gold, Credit And The Coming Financial Collapse

Since 2016, the US Monetary Base has declined by about 23.68%. This is the deepest and longest decline since the Federal Reserve was formed. This should not be ignored. The last time there was a decline close to this magnitude,there was a sharp deflationary recession. That...
Hubert Moolman | October 25, 2019 |

Lufthansa, Osino Resources, Wirecard - exciting opportunities for investors

Social life has changed by 180 degrees since February 2020 with the spread of the Corona Virus Covid-19. Business people spend more time in video conferences than on planes, trains or cars. The time spent in the office is often minimized and work is done from home instead. Fam...
Mario Hose | April 23, 2020 |

Invasive Species

Invasive species: Any kind of living organism—an amphibian (like the cane toad), plant, insect, fish, fungus, bacteria, or even an organism's seeds or eggs—that is not native to an ecosystem and causes harm. They can harm the environment, the economy, or even human he...
Streetwise Reports | August 14, 2019 |

Silver: The HARD Look

In this week's commentary, I am going to respond to the rash of end-of-the-world emails and terror-stricken texts that bombarded me after the BLS reported a better-than-expected Non-Farm Payrolls number Friday that sent stocks screaming higher and the precious metals in...
Streetwise Reports | December 11, 2019 |

Nowhere to Hide

As I begin the weekly missive here on Thursday, the U.S. equity markets are experiencing the worst daily assault since that fateful day back in 1987, when the Dow lost 23% in a single trading session, sending thousands of Gucci-clad stockbrokers to the Sears re-fit aisle....
Streetwise Reports | March 17, 2020 |

Halliburton Shares Trade Higher on Q3 Earnings

Shares of Halliburton Co. at times traded greater than 8% higher after the firm reported improved Q3/19 earnings results versus Q2/19. This morning before the opening bell Halliburton Co. (HAL:NYSE) announced its third quarter earnings for the period ending Septemb...
Streetwise Reports | October 23, 2019 |

Is the Fed Gearing Up for a New Round of Quantitative Easing? Here Are the Possible Signs

“This is not QE. In no sense is this QE.” That was Jerome Powell in early October, answering a reporter’s question on whether the Federal Reserve’s intervention in the overnight U.S. repo market constituted anoth...
Frank Holmes | December 11, 2019 |

Syndax Pharma Shares Rise on $35M Capital Raise, Credit Line and Positive Phase 1/2 Leukemia ...

Syndax Pharma Shares Rise on $35M Capital Raise, Credit Line and Positive Phase 1/2 Leukemia Trial Results Syndax Pharmaceuticals' shares traded 30% higher after the company reported it expects to raise $35 million from a common stock offering from five instituti...
Streetwise Reports | February 3, 2020 |
1 2 3 4